Nascent Biotech, Inc.
Nascent Biotech, Inc. (NBIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
NBIO · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsNascent Biotech, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nascent Biotech, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nascent Biotech, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Nascent Biotech, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NBIO revenue · 4 questionsNBIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Nascent Biotech, Inc. SEC filings · GAAP · Nascent Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026